AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today ...
Trial will evaluate the safety and effectiveness of the AtriCure Isolator ® Synergy™ EnCompass ® clamp and AtriClip ® Left Atrial Appendage Exclusion System to reduce the occurrence of new-onset ...
New technology combines Pulsed Field Ablation (PFA) and Advanced Radiofrequency Ablation with AtriCure’s EnCompass ® clamp to reduce treatment time for surgical ablation patients MASON, Ohio, December ...
MASON, Ohio - AtriCure, Inc. (NASDAQ: ATRC), a company specializing in medical devices for atrial fibrillation (Afib) and related conditions, has recently obtained regulatory approval to market its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results